OMCL
Omnicell, Inc.
43.44
1 x 43.34
1 x 43.57
bid
ask
+
0.64
1.50%
1 @ 07:00 AM
44.00 +0.56 (1.29%)
Ytd -4.11%
1y 39.41%
42.19
day range
44.09
22.66
52 week range
55.00
Open 42.54 Prev Close 42.80 Low 42.19 High 44.09 Mkt Cap 1.98B
Vol 841.33K Avg Vol 650.79K EPS 0.44 P/E 98.73 Forward P/E 19.50
Beta 0.86 Short Ratio 5.40 Inst. Own 105.98% Dividend N/A Div Yield N/A
Ex Div Date N/A Earning 04-28 50-d Avg 37.40 200-d Avg 36.90 1yr Est 61.29
Earning
Date For Estimate Reported Surprise surprise %
2026-04-28 2026-03 0.33 0.55 0.22 66.67%
2026-02-05 2025-12 0.47 0.4 -0.07 -14.89%
2025-10-30 2025-09 0.36 0.51 0.15 41.67%
2025-07-31 2025-06 0.31 0.45 0.14 45.16%
2025-05-06 2025-03 0.16 0.26 0.1 62.50%
2025-02-06 2024-12 0.57 0.6 0.03 5.26%
Upgrade / Downgrade
Date Firm Action From To
2026-04-29 Keybanc Upgrade Overweight Overweight
2026-04-23 Wells Fargo Upgrade Overweight Overweight
2026-02-06 Piper Sandler Upgrade Overweight Overweight
2026-02-02 Benchmark Upgrade Buy Buy
2026-01-08 Keybanc Upgrade Sector Weight Overweight
2026-01-05 Wells Fargo Upgrade Overweight Overweight
Profile
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Insider Holder
Date Name Relation Quantity Description
2025-05-29 BAUER JOANNE B Director 44.90K Stock Award(Grant)
2025-03-06 ETTA NCHACHA E. Chief Financial Officer 132.02K Stock Award(Grant)
2026-03-31 LIPPS RANDALL A Chief Executive Officer 899.44K Stock Award(Grant)
2026-03-31 MANLEY COREY J Officer 121.85K Stock Award(Grant)
2026-03-31 NJOKU NNAMDI Chief Operating Officer 161.54K Stock Award(Grant)
2026-03-31 NUTT BRIAN H Officer 23.09K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Blackrock Inc. 7.54M 327.42M 16.57%
2025-12-30 Vanguard Group Inc 5.55M 241.28M 12.21%
2025-12-30 Dimensional Fund Advisors LP 2.31M 100.48M 5.09%
2025-12-30 Wellington Management Group, LLP 2.08M 90.17M 4.56%
2025-12-30 State Street Corporation 1.96M 85.03M 4.30%
2025-12-30 Millennium Management Llc 1.74M 75.81M 3.84%
Fund Ownership
Report Date Organization Position Value Percentage
2026-03-30 iShares Trust-iShares Core S&P Small-Cap ETF 2.69M 117.05M 5.92%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 1.38M 59.95M 3.03%
2026-03-30 iShares Trust-iShares Russell 2000 ETF 1.08M 47.11M 2.38%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 965.66K 41.96M 2.12%
2026-02-27 Delaware Group Equity Funds V-Nomura Small Cap Core Fund 855.48K 37.17M 1.88%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund 623.78K 27.10M 1.37%